Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Shares Outstanding (Diluted Average) (2018 - 2020)

Avai Bio's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $26.3 million for Q4 2020.

  • For Q4 2020, Shares Outstanding (Diluted Average) rose 424.16% year-over-year to $26.3 million; the TTM value through Dec 2020 reached $26.3 million, up 424.16%, while the annual FY2020 figure was $1.0 million, 78.06% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2020 was $26.3 million at Avai Bio, roughly flat from $26.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $26.3 million in Q2 2020 and bottomed at $960641.0 in Q3 2018.
  • The 3-year median for Shares Outstanding (Diluted Average) is $5.0 million (2018), against an average of $9.9 million.
  • The largest YoY upside for Shares Outstanding (Diluted Average) was 424.16% in 2020 against a maximum downside of 78.06% in 2020.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $5.0 million in 2018, then changed by 0.0% to $5.0 million in 2019, then soared by 424.16% to $26.3 million in 2020.
  • Per Business Quant, the three most recent readings for AVAI's Shares Outstanding (Diluted Average) are $26.3 million (Q4 2020), $26.3 million (Q3 2020), and $26.3 million (Q2 2020).